Skip to main content
. 2026 Jun 18;18(6):749. doi: 10.3390/pharmaceutics18060749
AD Atopic Dermatitis
API Active Pharmaceutical Ingredient
CV coefficient of variation
DHPV 5-(3′,4′-Dihydroxyphenyl)-γ-valerolactone
FTIR Fourier Transform Infrared Spectroscopy
HPLC High-Performance Liquid Chromatography
IVRR In vitro release rate
MAPK Mitogen-Activated Protein Kinase
MCT Medium-Chain Triglycerides
NF-κB Nuclear Factor kappa B
NMR Nuclear Magnetic Resonance
PEG Polyethylene Glycol
Ph. Eur. European Pharmacopoeia
PXRD Powder X-ray Diffraction
ROS Reactive Oxygen Species
RSD Relative Standard Deviation
SEM Scanning Electron Microscopy
TEWL Transepidermal Water Loss
W/O Water-in-Oil
O/W Oil-in-Water
ICH International Council for Harmonisation
RH Relative Humidity